Literature DB >> 16212720

Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002--a remaining problem in the highly active antiretroviral therapy era.

J Brännström1, B Akerlund, M Arneborn, A Blaxhult, J Giesecke.   

Abstract

Our objective was to analyse the characteristics of patients who were unaware of their HIV infection until they developed AIDS, in the period after introduction of highly active antiretroviral therapy. The complete national register of HIV and AIDS cases reported to the Department of Epidemiology at the Swedish Institute for Infectious Disease Control 1996-2002 was searched for cases diagnosed with HIV less than three months before AIDS diagnosis (so-called "late testers"). Of a total of 487 patients with AIDS, reported during the seven-year period, 219 (45%) were late testers. Their proportion of all AIDS cases increased from 22% in 1996 to 58% in 2002. Heterosexual route of transmission, age greater than 40 years, and foreign origin were all significant risk factors for being a late tester. Intravenous drug users were associated with a highly significant reduced risk. The group without previously known HIV infection represents an increasing part of all cases of AIDS. From a disease control and from a medical perspective, it is important to study this group further and discover what measures are needed for earlier identification and access to medical care.

Entities:  

Mesh:

Year:  2005        PMID: 16212720     DOI: 10.1258/095646205774357262

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  12 in total

1.  Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore.

Authors:  Ronaldo I Moreira; Paula M Luz; Claudio J Struchiner; Mariza Morgado; Valdilea G Veloso; Jeanne C Keruly; Beatriz Grinsztejn; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

2.  Who are California's late HIV testers? An analysis of state AIDS surveillance data, 2000-2006.

Authors:  Janet J Tang; Vivian Levy; Maria Teresa Hernandez
Journal:  Public Health Rep       Date:  2011 May-Jun       Impact factor: 2.792

3.  Concepts of risk among young Swedes tested negative for HIV in primary care.

Authors:  Monica Christianson; Ann Lalos; Eva E Johansson
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

4.  CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009.

Authors:  Kate Buchacz; Carl Armon; Frank J Palella; Rose K Baker; Ellen Tedaldi; Marcus D Durham; John T Brooks
Journal:  AIDS Res Treat       Date:  2011-09-20

5.  Fogging the issue of HIV - barriers for HIV testing in a migrated population from Ethiopia and Eritrea.

Authors:  Pille Lindkvist; Eva Johansson; Ingrid Hylander
Journal:  BMC Public Health       Date:  2015-02-05       Impact factor: 3.295

6.  Epstein Barr virus DNA analysis in blood predicts disease progression in a rare case of plasmablastic lymphoma with effusion.

Authors:  Anna Friis; Börje Akerlund; Birger Christensson; Katarina Gyllensten; Anna Aleman; Jie-Zhi Zou; Ingemar Ernberg
Journal:  Infect Agent Cancer       Date:  2013-07-23       Impact factor: 2.965

7.  Late Presentation of HIV Infection: Prevalence, Trends, and the Role of HIV Testing Strategies in Guangzhou, China, 2008-2013.

Authors:  Weibin Cheng; Weiming Tang; Zhigang Han; Thitikarn May Tangthanasup; Fei Zhong; Faju Qin; Huifang Xu
Journal:  Biomed Res Int       Date:  2016-09-27       Impact factor: 3.411

8.  Health Literacy and Awareness of Atrial Fibrillation.

Authors:  Stephanie R Reading; Alan S Go; Margaret C Fang; Daniel E Singer; In-Lu Amy Liu; Mary Helen Black; Natalia Udaltsova; Kristi Reynolds
Journal:  J Am Heart Assoc       Date:  2017-04-11       Impact factor: 5.501

9.  Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study.

Authors:  Johanna Brännström; Veronica Svedhem; Gaetano Marrone; Örjan Andersson; Farshad Azimi; Anders Blaxhult; Anders Sönnerborg
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

10.  Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population level.

Authors:  Dario A Dilernia; Daniela C Monaco; Carina Cesar; Alejandro J Krolewiecki; Samuel R Friedman; Pedro Cahn; Horacio Salomon
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.